Advances in PET/CT Imaging for Breast Cancer
- PMID: 37445572
- PMCID: PMC10342839
- DOI: 10.3390/jcm12134537
Advances in PET/CT Imaging for Breast Cancer
Abstract
One out of eight women will be affected by breast cancer during her lifetime. Imaging plays a key role in breast cancer detection and management, providing physicians with information about tumor location, heterogeneity, and dissemination. In this review, we describe the latest advances in PET/CT imaging of breast cancer, including novel applications of 18F-FDG PET/CT and the development and testing of new agents for primary and metastatic breast tumor imaging and therapy. Ultimately, these radiopharmaceuticals may guide personalized approaches to optimize treatment based on the patient's specific tumor profile, and may become a new standard of care. In addition, they may enhance the assessment of treatment efficacy and lead to improved outcomes for patients with a breast cancer diagnosis.
Keywords: 18F-FDG; PET radiotracers; breast cancer; triple negative breast cancer (TNBC).
Conflict of interest statement
Capaccione has served as an advisor for Cardinal Health. Salvatore is a speaker and consultant for Genentech and Boehringer Ingelheim, and has received grant funding from Genentech and Boehringer Ingelheim. The remaining authors have nothing to disclose. No funding was obtained for this study.
Figures
References
-
- Siegel R.L., Miller K.D., Jemal A. Cancer statistics, 2017. CA: A Cancer. J. Clin. 2017;67:7–30. - PubMed
-
- United Nations Development Programme Human Development Data Center. [(accessed on 27 January 2021)]. Available online: http://hdr.undp.org/en/data.
-
- Cancer Research UK Breast Cancer Statistics. 2021. [(accessed on 31 August 2021)]. Available online: https://www.cancerresearchuk.org/health-professional/cancer-statistics/s....
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
